Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention-State, Tribal, Local and Territorial (STLT) Subcommittee, 58478-58479 [2015-24666]

Download as PDF 58478 Federal Register / Vol. 80, No. 188 / Tuesday, September 29, 2015 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Meeting of the Advisory Committee on Immunization Practices (ACIP) In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to PAR14–227, Workers’ Compensation Surveillance. 8:00 a.m.–7:00 p.m., EST, November 3–5, 2015 (Closed). TIME AND DATE: Internet Assisted Meeting (IAM)/ Virtual Meeting. PLACE: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. STATUS: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Workers’ Compensation Surveillance, PAR14–227, initial review.’’ MATTERS FOR DISCUSSION: CONTACT PERSON FOR MORE INFORMATION: asabaliauskas on DSK5VPTVN1PROD with NOTICES Donald Blackman, Ph.D., Scientific Review Officer, CDC, 2400 Century Center Parkway, NE., 4th Floor, Room 4204, Mailstop E–74, Atlanta, Georgia 30345, Telephone: (404) 498–6185, DYB7@CDC.GOV . The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 2015–24658 Filed 9–28–15; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 17:54 Sep 28, 2015 Jkt 235001 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following meeting of the aforementioned committee. TIME AND DATE: 8:00 a.m.–6:00 p.m., EDT, October 21, 2015. PLACE: CDC, Tom Harkin Global Communications Center, 1600 Clifton Road NE., Building 19, Kent ‘‘Oz’’ Nelson Auditorium, Atlanta, Georgia 30329. STATUS: Open to the public, limited only by the space available. Time will be available for public comment. The public is welcome to submit written comments in advance of the meeting. Comments should be submitted in writing by email to the contact person listed below. The deadline for receipt October 12, 2015. All requests must contain the name, address, and organizational affiliation of the speaker, as well as the topic being addressed. Written comments should not exceed one single-spaced typed page in length and delivered in 3 minutes or less. Please note that the public comment period may end before the time indicated, following the last call for comments. Members of the public who wish to provide public comments should plan to attend the public comment session at the start time listed. Written comments received in advance of the meeting will be included in the official record of the meeting. The meeting will be webcast live via the World Wide Web; for instructions and more information on ACIP please visit the ACIP Web site: https:// www.cdc.gov/vaccines/acip/. PURPOSE: The committee is charged with advising the Director, CDC, on the appropriate use of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding the appropriate periodicity, dosage, and contraindications applicable to the vaccines. Further, under provisions of the Affordable Care Act, at section 2713 of the Public Health Service Act, immunization recommendations of the PO 00000 Frm 00017 Fmt 4703 Sfmt 4703 ACIP that have been adopted by the Director of the Centers for Disease Control and Prevention and appear on the CDC immunization schedules must be covered by applicable health plans. MATTERS FOR DISCUSSION: The agenda will include discussions on: child and adolescent immunization schedule; adult immunization schedule; meningococcal vaccines; human papillomavirus vaccines; influenza; combination vaccine (pediatric hexavalent vaccine (DTaP–IPV-HibHepB); cholera vaccine; Japanese encephalitis vaccine; Ebola vaccine trial update and vaccine supply. Recommendation votes are scheduled for child and adolescent immunization schedule and adult immunization schedule. Agenda items are subject to change as priorities dictate. CONTACT PERSON FOR MORE INFORMATION: Stephanie Thomas, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road NE., MS–A27, Atlanta, Georgia 30329, telephone 404/ 639–8836; Email ACIP@CDC.GOV. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 2015–24656 Filed 9–28–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention—State, Tribal, Local and Territorial (STLT) Subcommittee In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned subcommittee: TIME AND DATE: 8:30 a.m.–4:00 p.m. EDT, October 21, 2015. PLACE: CDC, Building 19, Rooms 254/ 255, 1600 Clifton Road NE., Atlanta, Georgia 30333. E:\FR\FM\29SEN1.SGM 29SEN1 Federal Register / Vol. 80, No. 188 / Tuesday, September 29, 2015 / Notices Open to the public, limited only by the space available. The meeting room accommodates approximately 20 people. The public is welcome to participate during the public comment, which is tentatively scheduled from 3:15 to 3:35 p.m. This meeting is also available by teleconference. Please dial (888) 233–0592 and enter code 33288611. Web Links: STATUS: Windows Media: https:// wm.onlinevideoservice.com/CDC1 Flash: https:// www.onlinevideoservice.com/clients/ CDC/?mount=CDC3 Smart Phones and Mobile devices: https:// wowza01.sea.onlinevideoservice.com/ live/CDC3/playlist.m3u8 Technical Support: 404–639–3737 The Subcommittee will provide advice to the CDC Director through the ACD on strategies, future needs, and challenges faced by State, Tribal, Local and Territorial health agencies, and will provide guidance on opportunities for CDC. PURPOSE: The STLT Subcommittee members will discuss progress on implementation of ACDadopted recommendations related to health departments of the future, other emerging challenges, and how CDC can best support STLT health departments in the transforming health system. The agenda is subject to change as priorities dictate. MATTERS FOR DISCUSSION: asabaliauskas on DSK5VPTVN1PROD with NOTICES CONTACT PERSON FOR MORE INFORMATION: Judy Monroe, M.D., Designated Federal Officer, State, Tribal, Local and Territorial Subcommittee, Advisory Committee to the Director, CDC, 1600 Clifton Road NE., M/S E–70, Atlanta, Georgia 30333 Telephone (404) 498– 0300, Email: OSTLTSDirector@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 2015–24666 Filed 9–28–15; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 17:54 Sep 28, 2015 Jkt 235001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Statement of Organization, Functions, and Delegations of Authority Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–76, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 80 FR 53799, dated September 8, 2015) is amended to reflect the reorganization to establish the Office of Financial Resources within the Office of the Chief Operating Officer, Centers for Disease Control and Prevention. Section C–B, Organization and Functions, is hereby amended as follows: Delete in its entirety the mission and function statements for the Office of the Chief Operating Officer (CAJ) and insert the following: Office of the Chief Operating Officer (CAJ). (1) Provides leadership, direction, support, and assistance to CDC’s programs and activities to enhance CDC’s strategic position in public health; ensure responsible stewardship; maintain core values; optimize operational effectiveness of business services; and institutionalize accountability for achieving management initiatives; (2) directs the conduct of operational activities including, among others, facilities and real property planning and management; grants, procurement and materiel management; budget formulation/execution and finance/ accounting; human resources management; information technology and systems planning and support; internal security and emergency preparedness; and management analysis and services; (3) manages the planning, evaluation, and implementation of continuous improvement and reengineering initiatives and adoption of innovations and technologies in these areas and ensures that they are undertaken in a comprehensive and integrated manner; (4) maintains liaison with officials of the Department of Health and Human Services (HHS) responsible for the direction and conduct of the HHS program support and management services functions; (5) provides assistance to HHS officials and to CDC’s Centers/Institute/Offices (CIO) to assure that the human resources of PO 00000 Frm 00018 Fmt 4703 Sfmt 4703 58479 CDC are sufficient in numbers, training, and diversity to effectively conduct the public health mission of CDC; (6) provides guidance and ensures compliance with the budget priorities established by the Office of the Director, CDC; and (7) plans and coordinates the implementation of various federal administrative, statutory, regulatory, and policy requirements. Office of the Director (CAJ1). (1) Manages and directs the activities and functions of the Office of the Chief Operating Officer; (2) provides guidance and support in the conduct of agencywide business services and management activities performed for or by CIOs; (3) participates in the development of CDC’s priority areas, goals and objectives; (4) advises and assists the CDC Director, and other key officials on all aspects of business service activities and functions; (5) oversees operation of the Working Capital Fund (6) oversees governance of the Agency’s labor management activities; (7) evaluates and conducts agency-wide enterprise risk monitoring and management; and (8) coordinates responses to Office of the Inspector General hotline and other special investigations. Delete in its entirety the mission and function statements for the Office of the Chief Financial Officer (CAJE) and insert the following: Office of Financial Resources (CAJE). (1) Provides leadership, direction, and guidance in matters regarding CDC/ ATSDR financial resources, in support of the agency’s public health science and programs; (2) plans, develops, and implements policies, procedures, and practices to ensure effective customer service, consultation, and oversight in financial management, grants, and acquisition processes; (3) engages CDC/ ATSDR Centers/Institute/Offices (CIOs), as well as other key stakeholders to align agency-wide financial management, grants, and acquisition processes with applicable laws, regulations, and policies, and with CDC/ ATSDR public health goals, and (4) provides all support necessary to help ensure that appropriated funds are utilized in compliance with Congressional mandate, for the sole purpose of preventing and controlling infectious diseases domestically and globally. Office of the Director (CAJE1). (1) Provides overall leadership, direction, guidance, oversight, and coordination in the areas of finance and accounting services, acquisition services, budget services, and grants services; (2) provides overall leadership, direction, guidance, oversight, and coordination in the areas of organizational management, E:\FR\FM\29SEN1.SGM 29SEN1

Agencies

[Federal Register Volume 80, Number 188 (Tuesday, September 29, 2015)]
[Notices]
[Pages 58478-58479]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-24666]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee to the Director (ACD), Centers for Disease 
Control and Prevention--State, Tribal, Local and Territorial (STLT) 
Subcommittee

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
subcommittee:

Time and Date: 8:30 a.m.-4:00 p.m. EDT, October 21, 2015.

Place:  CDC, Building 19, Rooms 254/255, 1600 Clifton Road NE., 
Atlanta, Georgia 30333.

[[Page 58479]]


Status:  Open to the public, limited only by the space available. The 
meeting room accommodates approximately 20 people. The public is 
welcome to participate during the public comment, which is tentatively 
scheduled from 3:15 to 3:35 p.m. This meeting is also available by 
teleconference. Please dial (888) 233-0592 and enter code 33288611.
    Web Links:

Windows Media: https://wm.onlinevideoservice.com/CDC1
Flash: https://www.onlinevideoservice.com/clients/CDC/?mount=CDC3
Smart Phones and Mobile devices: https://wowza01.sea.onlinevideoservice.com/live/CDC3/playlist.m3u8
Technical Support: 404-639-3737


Purpose:  The Subcommittee will provide advice to the CDC Director 
through the ACD on strategies, future needs, and challenges faced by 
State, Tribal, Local and Territorial health agencies, and will provide 
guidance on opportunities for CDC.

Matters For Discussion:  The STLT Subcommittee members will discuss 
progress on implementation of ACD-adopted recommendations related to 
health departments of the future, other emerging challenges, and how 
CDC can best support STLT health departments in the transforming health 
system.
    The agenda is subject to change as priorities dictate.

Contact Person For More Information:  Judy Monroe, M.D., Designated 
Federal Officer, State, Tribal, Local and Territorial Subcommittee, 
Advisory Committee to the Director, CDC, 1600 Clifton Road NE., M/S E-
70, Atlanta, Georgia 30333 Telephone (404) 498-0300, Email: 
OSTLTSDirector@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 2015-24666 Filed 9-28-15; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.